AssayQuant Technologies, Inc.

AssayQuant Technologies, Inc.

Private
Marlborough, MassachusettsHealthcare & Life Scienceshttps://www.assayquant.com/

Last Round

Grant

Aug 15, 2024

Total Funding Raised

$5.59M

Company Overview

AssayQuant Technologies, Inc. is a discovery tools company that develops and commercializes real-time, continuous enzyme activity assays, reagents, and services for drug discovery research.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

enzyme activity assayskinase assayscontract research organizationCROdrug discovery serviceskinase inhibitorsmechanism of action studiesMOA studiesselectivity profilinglife science reagentsreal-time assaysphosphatase assayshigh-throughput screeningHTScustom assay developmenttime-dependent inhibition characterizationTDI characterization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AssayQuant Technologies, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AssayQuant Technologies, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantAug 15, 2024
VC RoundMar 12, 2024
VC RoundOct 1, 2023
Convertible DebtJul 12, 2023
AngelMay 14, 2021

Key People

Founding team and executive leadership

Barbara Imperiali

Co-founder And Chief Technology Officer

Founding Team

E. William Radany

Chief Executive Officer

Executive Team

AssayQuant Technologies, Inc. Investors

Notable investors and investment history

InvestorRounds
National Cancer InstituteGrant
NIH RADxGrant
Future Labs CapitalSeries B, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 9, 2025

    Added BIOMEDICA Medizinprodukte GmbH, a medical device distributor, as a customer.

AssayQuant Technologies, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AssayQuant Technologies, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AssayQuant Technologies, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMarlborough, Massachusetts
Employee Range20
Year Founded2015
Last FundingAug 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.